Evidence map›Paper›PMID 41550141›Full record

ArticleComputational and structural biotechnology journal2026

Digital modeling of metformin and diet interactions on gut-microbiota metabolism in prediabetic patients.

Juan José Oropeza-Valdez, Cristian Padron-Manrique, Jorge E Arellano-Villavicencio, Aarón Vázquez-Jiménez, Laura E Hernández-Juárez, Xavier Soberon, María de Lourdes Reyes-Escogido, Rodolfo Guardado-Mendoza, Osbaldo Resendis-Antonio

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juan José Oropeza-ValdezHuman Systems Biology Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico.
Cristian Padron-ManriqueCentro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.
Jorge E Arellano-VillavicencioHuman Systems Biology Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico.
Aarón Vázquez-JiménezHuman Systems Biology Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico.
Laura E Hernández-JuárezHuman Systems Biology Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico.
Xavier SoberonCentro de Ciencias de la Complejidad, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.
María de Lourdes Reyes-EscogidoMetabolic Research Laboratory, Department of Medicine and Nutrition, University of Guanajuato, León, Guanajuato, Mexico.
Rodolfo Guardado-MendozaMetabolic Research Laboratory, Department of Medicine and Nutrition, University of Guanajuato, León, Guanajuato, Mexico.
Osbaldo Resendis-AntonioHuman Systems Biology Laboratory, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prediabetes confers a high risk of progressing to type 2 diabetes mellitus (T2DM). While metformin, a first-line T2DM therapy, improves glycemic control in prediabetes, its effects on the gut microbiota and host metabolic shifts remain poorly understood. Here, we applied a genome-scale community metabolic modeling to build a personalized "digital microbiota" for analyzing the metabolic activity of gut microbes in 106 samples of Mexican prediabetic patients, distributed among patients without treatment and patients treated with metformin over baseline, 6 and 12 months. To contrast microbial metabolic activity across groups and explore how diet modulates it, we simulated computationally the microbial metabolic fluxes under Western, Mediterranean, and traditional Milpa diets across the three groups. As expected, in general terms

Indexed as

Genome-scale metabolic modelingGut microbiotaMetforminPersonalized nutritionPrediabetes

Identifiers

PMID41550141
PMCPMC12810558

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.